On the other hand, treating moderate to severe AD is more challenging; it requires additional systemic treatment strategies such as biologics, immunomodulating agents, allergen immunotherapy (AIT), anti-IgE therapy, and in worst cases phototherapy [158] and hospitalization. The gene discussed is IGHE; the disease is Alzheimer disease.